P
PathAI
Biotech & Life Sciences · Boston, United States · Founded 2016
AI-powered pathology platform optimizing diagnostic accuracy and research MoreLess
PathAI is dedicated to improving patient outcomes through its AI-powered pathology platform. The company focuses on enhancing the accuracy of diagnoses and the efficacy of treatments for diseases such as cancer by leveraging advanced machine learning techniques. PathAI serves healthcare providers, research institutions, and pharmaceutical companies, operating primarily in the medical and healthcare markets. The business model revolves around providing AI-driven diagnostic tools and services, generating revenue through partnerships, licensing, and service fees. The company is headquartered in Fenway and boasts a diverse team committed to solving complex problems and making a significant impact. PathAI has also been recognized as one of BBJ's Best Places to Work.
Keywords: AI, pathology, diagnosis, treatment, cancer, machine learning, healthcare, medical, patient outcomes, Fenway.
Company overview
PathAI company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2016
- Headquarters
- Boston, United States
- Employees
- 281
- Open positions
- 5
- Dealroom signal
- 84.1
- Investment activity
- 1 companies · latest Jul 2021
- Capital deployed
- —
- Preferred round
- ACQUISITION
Valuation & funding
PathAI funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | May 2026 | $750M | $750M | Roche | ↗ |
| DEBTDebt | Jan 2022 | $100M | — | Undisclosed | ↗ |
| SERIES COther financing | May 2021 | $165M | $660M | General Atlantic · Polaris Partners · LabCorp · Merck Global Health Innovation Fund | — |
| SERIES BOther financing | Nov 2019 | $15M | $60M | Bristol-Myers Squibb · Merck Global Health Innovation Fund · LabCorp | — |
| EARLY VCOther financing | Jul 2019 | $0 | — | LabCorp | — |
| SERIES BOther financing | Apr 2019 | General Atlantic | — | ||
| EARLY VCOther financing | Mar 2018 | Undisclosed | — | ||
| SERIES AOther financing | Nov 2017 | 8VC · General Catalyst · Refactor Capital · KdT Ventures | — | ||
| SEEDOther financing | Dec 2016 | Fairhaven Capital Partners · Refactor Capital · 8VC · Pillar VC | — | ||
| SPINOUTOther financing | Sep 2016 | Harvard University · Beth Israel Deaconess Medical Center | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $100M | 0% | 281 |
| 2025 | $100M | 0% | 270 |
| 2024 | $100M | — | 300 |
Growth signals
PathAI website traffic
Latest recorded traffic for PathAI is 73K monthly website visits, down 22.3% over the last three months. PathAI's team grew 4.1% over the past year.
Hiring
Open positions at PathAI
Current openings linked to this company in Dealroom.
Comparisons
PathAI compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
PathAI investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Talent graph
PathAI's talent
Source: Dealroom Talent Intelligence.
Investors
19 investors on PathAI's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Global footprint
Where PathAI has talent and traffic
team presence
In the news
Latest news about PathAI
Recent press, funding announcements, and product moves mentioning PathAI — open to read from the original sources.
Market sentiment
What the market is saying about PathAI
An AI-synthesized read of the highest-engagement posts about PathAI on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PathAI’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.